Received an order for ‘Cerviray’ from Health Technology, an international exhibition in Mongolia
[View original text]
On 16th of October, AIDOT (CEO Jae-hoon Jeong), a medical artificial intelligence (AI) solution company, announced that it had signed a contract to export the cervical cancer
screening system 'Cerviray' worth $30,000 at the international exhibition 'Health Technology 2022' held in Ulaanbaatar, the capital of Mongolia.
A total of 80 organizations participated in the exhibition, including 13 Mongolian public and private hospitals, 14 medical devices and equipment organizations, 41 pharmaceutical
factories and pharmaceutical supply organizations.
The artificial intelligence-based cervical cancer reading system, Cerviray, is a system that combines a portable device with software that displays the presence, severity, and condition of the disease.
AIDOT is currently conducting a pilot project for 300 patients, led by Dr. Bayarsaikhan Luvsandorj from the National Cancer Center in Gobi, Mongolia, and plans to expand nationwide next year to start full-fledged cervical cancer tests.
An official from AIDOT said, "The contract with a local medical device company in Mongolia has been completed and we have secured more than $30,000 in initial exports," adding,
"We will spare no effort to eradicate cervical cancer in Mongolia by utilizing international support funds such as the United Nations International Fund next year."
16th. Oct. 2022. / DailyMedi / Reporter Kyo-yoon Gu
Comments can be added by Member only